Diagnostic and Interventional Cardiology DAIC

Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.

AB-1002 is being studied for the treatment of adults with non-ischemic cardiomyopathy and New York Heart Association (NYHA) Class III heart failure symptoms

News | FDA

AskBio Receives FDA Fast Track Designation for AB-1002 Investigational Gene Therapy Program in Congestive Heart Failure

April 18, 2024 — Bayer AG and Asklepios BioPharmaceutical, Inc., a gene therapy company wholly owned and independently ...

April 18, 2024

Getinge and Cook Medical announced an exclusive sales and distribution agreement for the iCast covered stent system, which has been on the market for twenty years and recently received premarket approval for treatment of iliac arterial occlusive disease

News | Stents

Getinge Enters into Commercial Distribution Agreement with Cook Medical for iCast Covered Stent System in the United States

April 17, 2024 — Getinge and Cook Medical announced an exclusive sales and distribution agreement for the iCast covered ...

April 17, 2024

News | Heart Valve Technology

CPR-Therapeutics, Inc. Names Mike Black as Chief Strategy Officer

April 17, 2024 —CPR Therapeutics, Inc. (CPR-T), an early-stage medtech startup funded by the N.I.H and N.S.F to develop ...

April 17, 2024

Complications during procedures only contributed to death in about 20% of cases

News | Heart Failure

Around 10% of Deaths from Coronary Stenting, Balloon Angioplasty are Preventable

April 16, 2024 — Each year more than 500,000 Americans undergo percutaneous coronary intervention, or PCI, a minimally ...

April 16, 2024

Investigational technology designed for patients undergoing emerging large bore percutaneous catheter-based venous interventional procedures

News | Vascular Closure Devices

Vivasure Medical Announces First Large Hole Venous Patient Treated with PerQseal Elite Vascular Closure System

April 16, 2024 — Vivasure Medical, a company pioneering novel fully absorbable technology for percutaneous vessel ...

April 16, 2024

News | Cardiovascular Clinical Studies

CVRx Announces Availability of Additional Data Supporting Long-term Benefits of Barostim

April 16, 2024 — CVRx, Inc., a commercial-stage medical device company, announced today the availability of additional ...

April 16, 2024

Abbott/Thoratec Corp. is recalling HeartMate II and HeartMate 3 Left Ventricular Assist System (LVAS) due to an issue called Extrinsic Outflow Graft Obstruction, (EOGO).

News | FDA

FDA Announces Recalls of Abbott/Thoratec Corp. Heartmate II and Heartmate 3 Left Ventricular Assist System (LVAS) Due to Long-term Buildup of biological material Causing an Obstruction

April 15, 2024 — The U.S. Food and Drug Administration (FDA) announced Abbott/Thoratec Corp. is recalling HeartMate II ...

April 15, 2024

The Acolyte System is intended to provide interventional cardiologists with a more reliable and predictable tool to facilitate revascularization of chronic total occlusion (CTO)

News | FDA

Simpson Interventions Receives FDA Breakthrough Device Designation for Acolyte Image Guided Crossing and Re-Entry Catheter System

April 12, 2024 — Simpson Interventions, Inc., a pioneering medical technology company specializing in cardiovascular ...

April 12, 2024

University of Virginia School of Medicine researchers have discovered a gene on the Y chromosome that contributes to the greater incidence of heart failure in men.

News | Heart Failure

New Advance Against a Form of Heart Failure Prevalent in Men

April 12, 2024 — University of Virginia School of Medicine researchers have discovered a gene on the Y chromosome that ...

April 12, 2024

Trial bolsters evidence that less invasive strategy is safe and effective in younger, lower-risk patients

News | Cardiovascular Clinical Studies

TAVR Found Non-Inferior to SAVR for Low-Risk Patients

April 11, 2024 — Transcatheter aortic valve replacement (TAVR) was found to bring no increased risks and was associated ...

April 11, 2024

PCI shows substantial benefits over medications alone

News | Cardiovascular Clinical Studies

Preventive Percutaneous Coronary Intervention for High-Risk Coronary Plaques Reduces Cardiac Events

April 11, 2024 — People with a buildup of fatty atherosclerotic plaque in the heart’s arteries considered at risk of ...

April 11, 2024

A new technology using ultralow temperature cryoablation (ULTC), developed by Adagio Medical, has eliminated clinical ventricular tachycardia (VT) in 94% of patients. The late-breaking science was presented this week during EHRA 2024, a scientific congress of the European Society of Cardiology (ESC).

News | ESC

Cryocure-VT Trial Outcomes Presented in EHRA 2024 Late-Breaking Science Session

April 10, 2024 — A new technology using ultralow temperature cryoablation (ULTC) has eliminated clinical ventricular ...

April 10, 2024

Cathie Biga, MSN, FACC, today became president of the American College of Cardiology and made history as the organization’s first non-physician president.

News | Cardiovascular Business

Cathie Biga is New American College of Cardiology President

April 9, 2024 — Cathie Biga, MSN, FACC, today became president of the American College of Cardiology and made history as ...

April 09, 2024

UC Davis is one of the first sites nationwide to treat tricuspid regurgitation using a minimally invasive catheter system

News | Structural Heart

Cardiology Team Performs Novel Heart Artery Repair with Newly Approved Device

April 9, 2024 — UC Davis Health cardiology team members are among the first in the country to treat patients with tricus ...

April 09, 2024

Subanalysis finds benefit for patients not on heart-beneficial antidiabetic medication

News | Cardiovascular Clinical Studies

New Drug Fails to Improve Diabetes-Related Heart Failure

April 9, 2024 — One of the first studies to attempt to treat early-stage heart failure in patients with Type 2 diabetes ...

April 09, 2024